Cascara Sagrada Bark (Rhamnus purshiana)

Nomenclature & Taxonomic Classification

• Botanical Binomial: Rhamnus purshiana DC. (Syn: Frangula purshiana)
• Family: Rhamnaceae
• Common Name(s): Cascara Sagrada, Sacred Bark, Chittam Bark, Purshiana Bark
• Parts Used: Dried bark of the trunk and branches, aged for a minimum of one year or heat-cured.

Botanical Description, Habitat & Sustainability

• Physical Description: * Growth Habit: Deciduous shrub or small tree growing up to 4–10 meters tall.
  • Morphology: Smooth, gray to dark brown bark often covered with lichens. Leaves are alternate, ovate-oblong, with prominent, parallel lateral veins and finely serrated margins. Produces small, greenish flower clusters followed by black, fleshy drupes.
• Habitat & Cultivation: Native to the Pacific Northwest region of North America. Thrives in moist, rich soils of coniferous forest understories, river valleys, and mountain canyons.
• Sustainability Status: Historically over-harvested in the wild. Controlled wild-stripping guidelines require leaving the inner cambium intact or managing via sustainably cultivated bark orchards.

Energetics & Traditional Actions

• Western Tissue States: Corrects Torpor/Stagnation (resolves severe fecal stasis, atony, and physical obstruction in the colon).
• Traditional Vector:
  • Ayurveda: Rasa (Taste): Tikta (Bitter) | Virya (Energy): Sheeta (Cooling) | Vipaka (Post-Digestive Effect): Katu (Pungent) | Dosha Modulation: Decreases Kapha and Pitta; increases Vata via sharp downward movement.
  • Traditional Chinese Medicine: Temperature: Cold | Taste: Bitter | Organ Meridians Entered: Large Intestine, Liver, Gallbladder
• Historical Folk Use: Indigenous Pacific Northwest tribes passed knowledge of this bark to Spanish priests, who named it “Cascara Sagrada” (Sacred Bark) due to its reliable capacity to clear chronic, stubborn constipation.

Phytochemistry & Pharmacological Dynamics

• Primary Phytochemicals: Anthrone C-glycosides (cascarosides A, B, C, and D); anthraquinone O-glycosides; free anthraquinones (emodin, chrysophanol); tannins.
• Mechanism of Action: > Cascarosides resist cleavage in the upper digestive tract and enter the large intestine intact. Colonic anaerobic bacteria express specific enzymes that cleave the C-glycoside bonds, transforming them into active emodin anthrones. These active metabolites induce localized irritation of the colonic mucosa, directly exciting the myenteric plexus. This decreases transit time by accelerating propulsive peristalsis while simultaneously blocking the $Na^+/K^+-ATPase$ pump, creating a net influx of water and electrolytes into the fecal mass.

Clinical Applications & Indications

• Primary Indications: Acute or chronic atonic constipation, rehabilitation of sluggish bowel tone following laxative abuse, and evacuation management for severe hemorrhoids or anal fissures.
• Secondary Indications: Cholagogue support for sluggish hepatic flow and biliary insufficiency.
• Modern Clinical Evidence: Universally recognized in classic pharmacology texts as a dependable, highly effective stimulant laxative that predictably induces soft, formed evacuations within 6–12 hours of oral administration.

Preparation, Dosing & Extraction Matrix

• Optimal Menstruum & Extraction Guidelines: CRITICAL PROCESSING LAW: Freshly harvested bark contains free anthrones that act as potent local emetics, causing violent vomiting and severe abdominal cramps. Bark must be stored and aged for a minimum of 12 months, or heat-cured to oxidize anthrones into stable cascarosides. Soluble in water (decoction) or low-alcohol matrices (30–40% EtOH).

Standard Dosage Parameters

Safety Profile, Contraindications & Drug Interactions

• Contraindications: Strictly contraindicated in pregnancy, lactation, and children under 12. Absolutely prohibited in cases of intestinal obstruction, stenosis, appendicits, Crohn’s disease, ulcerative colitis, or undiagnosed abdominal pain. Restrict use to 7–10 consecutive days.
• Side Effects & Toxicity Thresholds: Long-term continuous use induces colonic muscular atony (dependency) and severe electrolyte imbalances (particularly hypokalemia). May cause a harmless red-orange discoloration of urine and reversible benign pigmentation of the colonic mucosa (pseudomelanosis coli).
• Pharmaceutical Cross-Interactions: * Enzyme Alterations: Minimal data available.
  • Additive Pathways: Hypokalemia induced by chronic use severely potentiates the toxicity of cardiac glycosides (digoxin) and anti-arrhythmics. Exacerbates potassium depletion when combined with thiazide diuretics, loop diuretics, or systemic corticosteroids.

References

1. Felter, H. W., & Lloyd, J. U. (1898). King’s American Dispensatory.
2. Mills, S., & Bone, K. (2005). The Essential Guide to Herbal Safety.
3. World Health Organization. (2002). WHO Monographs on Selected Medicinal Plants (Vol. 2).